Menu

Pharma News

Health on a Budget V13D12

Ireland high drug prices cannot be justified

Home/Pharma News | Posted 22/11/2013

The European Commission’s troika mission to Ireland has told Government TDs (Members of Parliament) that the cost of pharmaceutical drugs in the country cannot be justified. Drug prices in the country have been found to be at least three times more expensive than in the UK.

Drug Shortages FDA V13K15

EMA launches public catalogue of drug shortages

Home/Pharma News | Posted 15/11/2013

The European Medicines Agency (EMA) announced on 4 November 2013 the launch of its public catalogue on supply shortages of drugs.

picture28

FDA announces two actions to combat drug shortages

Home/Pharma News | Posted 08/11/2013

The US Food and Drug Administration (FDA) announced on 31 October 2013 that it is taking two important actions to further enhance the agency’s ongoing efforts to prevent and resolve drug shortages.

Health on a Budget V13D12

Australia should not copy New Zealand’s drug pricing system

Home/Pharma News | Posted 25/10/2013

Australia should resist ongoing pressure to adopt a New Zealand-style model of medicines funding, according to Medicines Australia, a group that represents originator manufacturers.

Internet Pharmacy V13J18

US state introduces law to allow meds to be bought over Internet

Home/Pharma News | Posted 18/10/2013

On 9 October 2013, the US state of Maine introduced a law allowing its residents to purchase foreign prescription drugs over the Internet.

Approved V13G05

India approves Mylan’s purchase of Agila

Home/Pharma News | Posted 11/10/2013

Generics giant Mylan announced on 3 September 2013 that its proposed acquisition of generics injectables maker Agila Specialties (Agila) from Strides Arcolab for Rs 5,168-crore (US$1.6 billion) had been cleared by the Indian Government.

Drug shortages V13C22

Johnson & Johnson warns of shortages of cancer drug Doxil

Home/Pharma News | Posted 04/10/2013

Janssen Pharmaceutical Companies (Janssen), a division of healthcare giant Johnson & Johnson, has warned of impending shortages of its ovarian cancer drug Doxil (doxorubicin).

SurePal Pen V13I27

Sandoz launches new device for its biosimilar somatropin

Home/Pharma News | Posted 27/09/2013

Sandoz, the generic drug division of Swiss drug giant Novartis, announced on 23 September 2013 the launch of a new delivery device for its biosimilar somatropin product (Omnitrope) in the UK.

Business Aquisition V13F07

Akorn to buy Hi-Tech Pharmacal for US$640 million

Home/Pharma News | Posted 13/09/2013

Generic eye-drugmaker Akorn has entered into a deal to buy Hi-Tech Pharmacal (Hi-Tech) for US$640 million in cash to expand into oral liquids and ointments, including cold and cough treatments.

Generic Brand Name V13C01

Endo to buy specialty generic drugmaker Boca Pharmacal

Home/Pharma News | Posted 06/09/2013

Specialty pharmaceutical maker Endo Health Solutions (Endo) announced on 28 August 2013 that its generics subsidiary, Qualitest, has agreed to buy specialty generic drugmaker Boca Pharmacal (Boca) for US$225 million in cash.